Risedronate in the Prevention of Osteoporosis in Postmenopausal Women

Clinical trial NCT00402441 · COMPLETED

Trial details

NCT number: NCT00402441
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2002-09-01
Primary completion: 2004-06-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.